These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
61 related articles for article (PubMed ID: 10075383)
1. Ca2+ channels of the L-type in peripheral blood lymphocytes of essential hypertensives. Ricci A; Bronzetti E; Ferrante F; Mignini F; Mulatero P; Schena M; Veglio F; Amenta F Am J Hypertens; 1999 Jan; 12(1 Pt 1):40-6. PubMed ID: 10075383 [TBL] [Abstract][Full Text] [Related]
2. Pharmacological characterisation of Ca2+ channels of the L-type in human peripheral blood lymphocytes. Ricci A; Bisetti A; Bronzetti E; Felici L; Ferrante F; Veglio F; Amenta F Eur J Pharmacol; 1996 Apr; 301(1-3):189-94. PubMed ID: 8773463 [TBL] [Abstract][Full Text] [Related]
3. Dopamine D5 receptor expression is unchanged in peripheral blood lymphocytes in essential hypertension. Ricci A; Chiandussi L; Schena M; Schiavone D; Veglio F; Amenta F Clin Exp Hypertens; 1995 Nov; 17(8):1157-72. PubMed ID: 8563694 [TBL] [Abstract][Full Text] [Related]
4. Dopamine D3 receptor in peripheral mononuclear cells of essential hypertensives. Ricci A; Bronzetti E; Mulatero P; Schena M; Veglio F; Amenta F Hypertension; 1997 Dec; 30(6):1566-71. PubMed ID: 9403584 [TBL] [Abstract][Full Text] [Related]
5. Density and localization of calcium channels of the L-type in human pulmonary artery. Amenta F; Bisetti A; Bronzetti E; Coppola L; Felici L; Ferrante F; Mariotta S; Ricci A Clin Exp Hypertens; 1998 May; 20(4):389-402. PubMed ID: 9607402 [TBL] [Abstract][Full Text] [Related]
6. Modulation of L-type Ca2+ channels in clonal rat pituitary cells by membrane depolarization. Liu J; Bangalore R; Rutledge A; Triggle DJ Mol Pharmacol; 1994 Jun; 45(6):1198-206. PubMed ID: 8022413 [TBL] [Abstract][Full Text] [Related]
7. Ca2+i:K+i ratio and total intracellular calcium in essential and renal hypertension. Zidek W; Spieker C; Vetter H J Hypertens; 1986 Aug; 4(4):507-10. PubMed ID: 3772102 [TBL] [Abstract][Full Text] [Related]
9. Localization of calcium channels of the L-type in human epicardial arteries: a light microscope autoradiographic study. Ferrante F; Cadoni A; Zaccheo D; Amenta F Clin Exp Hypertens; 1995 Aug; 17(6):895-912. PubMed ID: 7581260 [TBL] [Abstract][Full Text] [Related]
10. Voltage-dependent binding of 1,4-dihydropyridine Ca2+ channel antagonists and activators in cultured neonatal rat ventricular myocytes. Wei XY; Rutledge A; Triggle DJ Mol Pharmacol; 1989 Apr; 35(4):541-52. PubMed ID: 2539561 [TBL] [Abstract][Full Text] [Related]
11. Platelet calcium pump activity in essential hypertensives and their first-degree relatives. Gulati S; Khullar M; Sharma BK; Ganguly NK Mol Cell Biochem; 1996 Mar; 156(1):37-42. PubMed ID: 8709974 [TBL] [Abstract][Full Text] [Related]
12. Binding of the dihydropyridine calcium channel blocker (+)-[3H] isopropyl-4-(2,1,3-benzoxadiazol-4-yl)-1,4-dihydro-5-methoxycarbonyl-2, 6-dimethyl-3-pyridinecarboxylate (PN200-110) to RINm5F membranes and cells: characterization and functional significance. Yaney GC; Stafford GA; Henstenberg JD; Sharp GW; Weiland GA J Pharmacol Exp Ther; 1991 Aug; 258(2):652-62. PubMed ID: 1713965 [TBL] [Abstract][Full Text] [Related]
13. Identification, characterization, and photoaffinity labeling of the dihydropyridine receptor associated with the L-type calcium channel from bovine adrenal medulla. Murphy BJ; Rogers CA; Sunahara RK; Lemaire S; Tuana BS Mol Pharmacol; 1990 Feb; 37(2):173-81. PubMed ID: 2154669 [TBL] [Abstract][Full Text] [Related]
14. Regional expression and functional characterization of the L-type Ca2+-channel in myocardium from patients with end-stage heart failure and in non-failing human hearts. Schwinger RH; Hoischen S; Reuter H; Hullin R J Mol Cell Cardiol; 1999 Jan; 31(1):283-96. PubMed ID: 10072735 [TBL] [Abstract][Full Text] [Related]
15. Pharmacological, radioligand binding, and electrophysiological characteristics of FPL 64176, a novel nondihydropyridine Ca2+ channel activator, in cardiac and vascular preparations. Zheng W; Rampe D; Triggle DJ Mol Pharmacol; 1991 Nov; 40(5):734-41. PubMed ID: 1719369 [TBL] [Abstract][Full Text] [Related]
16. Autoradiographic localization of [3H]nicardipine binding sites in the human renal artery. Ferrante F; Amenta F Eur J Pharmacol; 1993 Aug; 240(2-3):229-34. PubMed ID: 8243541 [TBL] [Abstract][Full Text] [Related]
17. Ca2+ channel modulation alters halothane-induced depression of ventricular myocytes. Kanaya N; Matsumoto M; Kawana S; Tsuchida H; Kimura H; Miyamoto A; Ohshika H; Namiki A Can J Anaesth; 1998 Jun; 45(6):584-91. PubMed ID: 9669017 [TBL] [Abstract][Full Text] [Related]
18. [Regulation of platelet alpha2 adrenergic receptors in a population of patients with essential arterial hypertension and in normotensive subjects]. Fabris B; Fischetti F; Bulli G; Giraldi T; Castellano M; Beschi MG; Carretta R G Ital Cardiol; 1991 Jul; 21(7):717-23. PubMed ID: 1662651 [TBL] [Abstract][Full Text] [Related]
19. Identification of dihydropyridine (DHP) binding sites on cultured monkey renal cells (GMRC) with a photoaffinity probe (-)-[3H]-azidopine. DrĂmal J Gen Physiol Biophys; 1994 Apr; 13(2):137-48. PubMed ID: 7528701 [TBL] [Abstract][Full Text] [Related]
20. Voltage-dependent calcium channels in the rat retina: involvement in NMDA-stimulated influx of calcium. Melena J; Osborne NN Exp Eye Res; 2001 Apr; 72(4):393-401. PubMed ID: 11273667 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]